Evidence map›Paper›PMID 35321374›Full record

ArticleMedical journal of the Islamic Republic of Iran2021

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development.

Zahra Goudarzi, Shekoufeh Nikfar, Abbas Kebriaeezadeh, Reza Yousefi Zenouz, Akbar Abdollahi Asl, Nader Tavakoli

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zahra GoudarziDepartment of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Shekoufeh NikfarDepartment of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Abbas KebriaeezadehDepartment of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical sciences, Tehran, Iran.
Reza Yousefi ZenouzDepartment of Operations and Information Technology Management, Faculty of Management, Kharazmi University, Tehran, Iran.
Akbar Abdollahi AslDepartment of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-3686-4770
Nader TavakoliTrauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Stages of Technology DevelopmentEmerging PharmaceuticalsHealth Technology AssessmentNew Medical Technologies

Identifiers

PMID35321374
PMCPMC8840857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.